Literature DB >> 20185504

Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases.

S Kleinert, O Kurzai, J Elias, K Marten, C Engelke, M Feuchtenberger, J Sandstede, M Frosch, H-P Tony, C Kneitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20185504     DOI： 10.1136/ard.2009.113829

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.

Authors:  José M Ramos; Mar Masiá; Juan C Rodríguez; Cristina López; Sergio Padilla; Catalina Robledano; Francisco J Navarro-Blasco; Jaime Matarredona; Mariana F García-Sepulcre; Félix Gutiérrez
Journal:  Clin Exp Med       Date:  2012-06-27       Impact factor: 3.984

2.  Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Authors:  Sonia Mínguez; Irene Latorre; Lourdes Mateo; Alicia Lacoma; Jéssica Diaz; Alejandro Olivé; Jose Domínguez
Journal:  Clin Rheumatol       Date:  2012-01-21       Impact factor: 2.980

3.  Diagnosis of latent tuberculosis infection with T-SPOT(®).TB in a predominantly immigrant population with rheumatologic disorders.

Authors:  Patricio Escalante; Kirstin J Kooda; Rizwana Khan; San San Aye; Stratos Christianakis; Daniel G Arkfeld; Glenn R Ehresmann; Jens J Kort; Brenda E Jones
Journal:  Lung       Date:  2014-10-16       Impact factor: 2.584

4.  IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?

Authors:  Juan González-Moreno; Mercedes García-Gasalla; Inés Losada-López; Carmen Cifuentes Luna; Isabel Mir Viladrich; Victoria Fernández-Baca; Araceli Serrano; Antonio Juan Mas; Joan Riera-Oliver; Antoni Payeras Cifre
Journal:  Rheumatol Int       Date:  2017-10-19       Impact factor: 2.631

5.  [Tuberculosis : diagnostics and prophylaxis].

Authors:  N Görl; R Diel; C Kneitz
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

6.  Ocular Tuberculosis--A Clinical Conundrum.

Authors:  Cecilia Lee; Rupesh Agrawal; Carlos Pavesio
Journal:  Ocul Immunol Inflamm       Date:  2015-06-25       Impact factor: 3.070

7.  Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.

Authors:  Dimitrios Vassilopoulos; Stamatoula Tsikrika; Chrisoula Hatzara; Varvara Podia; Anna Kandili; Nikolaos Stamoulis; Emilia Hadziyannis
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

8.  Performance of QuantiFERON®-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs.

Authors:  Francesca Gabriele; Maria Trachana; Maria Simitsopoulou; Polixeni Pratsidou-Gertsi; Elias Iosifidis; Zoi Dorothea Pana; Emmanuel Roilides
Journal:  World J Pediatr       Date:  2017-06-22       Impact factor: 2.764

9.  Serial interferon-γ release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents.

Authors:  Rossana Scrivo; Ilaria Sauzullo; Fabio Mengoni; Giancarlo Iaiani; Anna Rita Vestri; Roberta Priori; Elisa Di Filippo; Manuela Di Franco; Francesca Romana Spinelli; Vincenzo Vullo; Claudio Maria Mastroianni; Guido Valesini
Journal:  Clin Rheumatol       Date:  2012-08-05       Impact factor: 2.980

10.  Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.

Authors:  Aran Singanayagam; Kavina Manalan; Saranya Sridhar; Philip L Molyneaux; David W Connell; Peter M George; Anne Kindelerer; Suranjith Seneviratne; Ajit Lalvani; Melissa Wickremasinghe; Onn Min Kon
Journal:  Thorax       Date:  2013-08-23       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.